Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...
Dr. Raches Ella, Chief Development Officer, Bharat Biotech, spearheading this CGT initiative, said that oncology and rare ...
Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
Sarepta Therapeutics said on Tuesday that a 16-year-old boy died from acute liver failure months after receiving the company's U.S-approved gene therapy for a rare muscular dystrophy. The patient ...
MyChesCo on MSN1d
ChromaTan and Landmark Bio Receive NIIMBL Grant to Advance AAV Gene Therapy ManufacturingChromaTan Inc. and Landmark Bio PBLLC have been awarded a grant from the National Institute for Innovation in Manufacturing ...
June 13, 2024 — A viral gene therapy has reversed some brain abnormalities in infant mice with FOXG1 syndrome, a significant step toward one day treating children with this severe neurodevelopmental ...
Hyderabad: Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and ...
A new study by researchers at Weill Cornell Medicine and Oregon Health & Science University (OHSU) provides critical insight for the development of a ...
Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback